GT Biopharma Inc. (OXISD) (OTCQB:GTBP), having acquired Georgetown Translational Pharmaceuticals (GTP), announced today that it has changed its stock trading symbol from “OXISD” to “GTBP” (OTCQB:GTBP). Earlier this month, GT Biopharma announced that it had completed the acquisition of GTP and retired more than $18 million of debt. Completion of the merger was a key step that allows GT Biopharma to consider applying for acceptance to the Nasdaq Exchange.
Submitted September 20, 2017 at 01:00PM by Bdavid5 http://ift.tt/2fjJOvj
No comments:
Post a Comment